Back

Disparities by region, age, and sex in cardiovascular disease burden attributable to high fasting plasma glucose in China, 2010-2018: a nationwide, population-based study.

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Disparities: insights into socioeconomic factors and cardiovascular health Public Health ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Miss Xue Cao

Fuwai Hospital, CAMS and PUMC, Beijing (China)

4 More presentations in this session

Presentation thumbnail
Cost differences between oral anticoagulation therapies in atrial fibrillation patients
Mr O. Lehtonen (Kuopio, FI)
Abstract Slides Video
Presentation thumbnail
Embedding a text message recall system to increase the uptake of cardiovascular screening in Australian general practice. Results of the Text to Detect randomised controlled trial
Miss N. Raffoul (Sydney, AU)
Abstract Slides Video
Presentation thumbnail
Independent associations of educational attainment and its joint associations with LE8 score for risk of cardiovascular disease incidence and mortality among Chinese people
Doctor Z. Chen (Changsha, CN)
Abstract Slides Video
Presentation thumbnail
Cost-effectiveness of semaglutide for secondary prevention of cardiovascular disease in the United States
Doctor S. Hennessy (San Francisco, US)
Abstract Slides Video

Access the full session

Session thumbnail
Disparities: insights into socioeconomic factors and cardiovascular health
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Association of triglyceride-glucose index and vascular aging with cardiovascular diseases in China: PURE cohort study
thumbnail
Congress Presentation
Association of socioeconomic status with premature cardiovascular mortality and its metabolic mediators: evidence from a nationwide cohort study
thumbnail
Congress Presentation
Trends and cross-country inequalities in the global burden of early-onset atherosclerosis - a population-based study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources